Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
A recent survey conducted by healthcare professionals revealed a concerning trend of the overuse of paracetamol tablets. The study found that an alarming number of people turn to this medication for every minor ailment instead of using it as directed. Some respondents admitted to taking more than the recommended dosage and ignoring warning labels, jeopardizing their health in the process. This misuse can lead to liver damage and other serious consequences, including death in rare cases. Health care providers are urging individuals to be responsible when taking medications and seek professional advice if they experience frequent pain or discomfort instead of relying on self-medication with paracetamol tablets.
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
Patients value communication skills from cancer surgeons across six key areas, according to research
3.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
1.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
2.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
3.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
4.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
5.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge